EcoDrugPlus

Ensembl ID : ENSLACG00000004229
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSLACG00000004644
Gene Symbol: RPL13
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSLACG00000016836
Gene Symbol: -
Cross references: -
320 Possible Orthologues:

Ensembl ID : ENSLACG00000005993
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Ensembl ID : ENSLACG00000013557
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSLACG00000010340
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSLACG00000018280
Gene Symbol: SLC22A6L
1 Cross references
345 Possible Orthologues:

Ensembl ID : ENSLACG00000002719
Gene Symbol: -
Cross references: -
10 Possible Orthologues:

Ensembl ID : ENSLACG00000005311
Gene Symbol: RPL13
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSLACG00000006589
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSLACG00000003502
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSLACG00000011158
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).